top of page

Our Mission

Human-Like Tissue

Utilizing a passionate and talented team, VoxCell is providing an extraordinary line of human-like tissue solutions for the drug development industry and the field of Oncology research by creating 3D vascularized cancer tissue models. Our 3D Bioprinter uses a state of the art laser with a process that crosslinks bioink with extreme precision, producing incredible high resolution 3D bioprinted tissues. Combined with our proprietary software, we are able to print tissues with vasculature for more meaningful in vitro testing. This process occurs only at the focal point of the laser (the voxel, hence VoxCell), allowing for printing anywhere in the polymer, including within structures, unlike traditional extrusion based 3D bioprinters.

Our tissue models will increase confidence in new drug candidates, decrease the failure rate (currently more than 95% of drugs in the pipeline fail), and impact the speed for new therapies to get to market. The successful translation between pre-clinical trial data and clinical trial results is less than 8% and we are on a mission to change that.

 

Testing on human-like tissues will provide better data to identify and eliminate unsuccessful drug candidates sooner, increasing the throughput and reducing the volume and cost of animal and human testing, ultimately getting life saving therapies to market and in the hands of people who need them sooner.

Meet The Team

DSC08919-Edit-2-Edit-2_edited.jpg
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO

Untitled design (5).png
Untitled design (3)_edited.png

Genevieve Boice, Ph.D.

Head of Bioinks

DSC08958-Edit_edited.jpg
Untitled design (3)_edited.png

Megan Chisling

Junior Biophotonics Engineer

DSC08980-Edit_edited.jpg
Untitled design (3)_edited.png

Asees Kaur

Junior Mechanical Engineer

Labcoat_Headshot_edited.jpg
Untitled design (3)_edited.png

Sam Paton

Biomedical Scientist

DSC09072-Edit_edited.jpg
Untitled design (3)_edited.png

Kevin Vos, Ph.D.

Director of Business Development and Strategic Alliances

DSC08925-Edit_edited.jpg
Untitled design (3)_edited.png

Shael Mazzone

Operations Manager

Byron Kontou_edited.png
Untitled design (3)_edited.png

Byron Kontou

Software Developer

DSC08992-Edit_edited.jpg
Untitled design (3)_edited.png

Benjamin Rampado

Chemist

Untitled design (8).png
Untitled design (3)_edited.png

Max Strasser

Student in Chemistry

Sebastian_edited.png
Untitled design (3)_edited.png

Sebastian Steiner, Ph.D.

Director of Engineering

DSC09120-Edit_edited.jpg
Untitled design (3)_edited.png

Cameron Polglase

Biophotonics Engineer

DSC08947-Edit_edited.jpg
Untitled design (3)_edited.png

Ian DeJong

Lead Software Engineer

DSC09027-Edit_edited.jpg
Untitled design (3)_edited.png

Annelise Lapointe

Junior Biomedical Engineer

ADvisors and partners

DSC09149-Edit_edited.jpg
Untitled design (3)_edited.png

Alexandre Brolo, Ph.D.

Partner

Alvin Chubbs.png
Untitled design (3)_edited.png

Alvin Chubbs

Advisor - Business & Finance

JH_edited.png
Untitled design (3)_edited.png

John Hossack, MBA.

Strategy & Growth

Nathan Lindquist.png
Untitled design (3)_edited.png

Nathan Lindquist, Ph.D.

Advisor - Optics.

Madhu Singh.png
Untitled design (3)_edited.png

Madhu Singh, Ph.D.

Advisor - Oncology

Untitled design (1).png
Untitled design (3)_edited.png

Erik Hadley, Ph.D.

Advisor - Business

Dave Leitch.png
Untitled design (3)_edited.png

Dave Leitch, Ph.D.

Advisor - Pharma

Georgina Rizik_edited.png
Untitled design (3)_edited.png

Georgina Rizik, MBA.

Advisor - Strategy

Scientific Advisors

Untitled design (11).png
Stanford-University-Logo.png
Untitled design (3)_edited.png

Mark Pegram, M.D.

Advisor

Stanford

Board Members

DSC08919-Edit-2-Edit-2_edited.jpg
Untitled design (3)_edited.png

Karolina Valente, Ph.D.

CEO & CSO, Board

Nina Vellani.png
Untitled design (3)_edited.png

Nina Vellani, Ph.D.

Board

Robert Levak.png
Untitled design (3)_edited.png

Robert Levak

Board

bottom of page